TY  - GEN
AU  - Alberts,M J
TI  - Hyperacute stroke therapy with tissue plasminogen activator
SN  - 0002-9149
PY  - 1997///0925
KW  - Acute Disease
KW  - Brain
KW  - drug effects
KW  - Brain Ischemia
KW  - drug therapy
KW  - Cerebral Hemorrhage
KW  - chemically induced
KW  - Cerebrovascular Disorders
KW  - Drug Approval
KW  - Drug Combinations
KW  - Emergency Medical Technicians
KW  - Enzyme Precursors
KW  - administration & dosage
KW  - Fibrinolytic Agents
KW  - Humans
KW  - Injections, Intra-Arterial
KW  - Magnetic Resonance Spectroscopy
KW  - Neurologic Examination
KW  - Neuroprotective Agents
KW  - Plasminogen Activators
KW  - Recombinant Proteins
KW  - Safety
KW  - Thrombolytic Therapy
KW  - Time Factors
KW  - Tissue Plasminogen Activator
KW  - Treatment Outcome
KW  - United States
KW  - United States Food and Drug Administration
KW  - Urokinase-Type Plasminogen Activator
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/s0002-9149(97)00582-1
ER  -